428 related articles for article (PubMed ID: 36306866)
1. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
[TBL] [Abstract][Full Text] [Related]
2. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
Saravanakumar K; Hu X; Ali DM; Wang MH
Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
[TBL] [Abstract][Full Text] [Related]
3. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
Agiba AM; Arreola-RamÃrez JL; Carbajal V; Segura-Medina P
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
[TBL] [Abstract][Full Text] [Related]
5. Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms.
Kaushik N; Borkar SB; Nandanwar SK; Panda PK; Choi EH; Kaushik NK
J Nanobiotechnology; 2022 Mar; 20(1):152. PubMed ID: 35331246
[TBL] [Abstract][Full Text] [Related]
6. Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.
Handa M; Singh A; Flora SJS; Shukla R
Curr Pharm Des; 2022; 28(11):910-921. PubMed ID: 34879797
[TBL] [Abstract][Full Text] [Related]
7. Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.
Sethuraman V; Janakiraman K; Krishnaswami V; Kandasamy R
Curr Drug Targets; 2021; 22(8):947-966. PubMed ID: 33511953
[TBL] [Abstract][Full Text] [Related]
8. Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases.
Sufi SA; Pajaniradje S; Mukherjee V; Rajagopalan R
Antioxid Redox Signal; 2019 Feb; 30(5):762-785. PubMed ID: 29334759
[TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms.
Chen X; Lei S; Lin J; Huang P
Expert Opin Drug Deliv; 2022 Nov; 19(11):1487-1504. PubMed ID: 36214740
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview.
Kapalatiya H; Madav Y; Tambe VS; Wairkar S
Drug Deliv Transl Res; 2022 Jun; 12(6):1293-1305. PubMed ID: 34251612
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices.
Zhang CW; Zhang JG; Yang X; Du WL; Yu ZL; Lv ZY; Mou XZ
Expert Opin Drug Deliv; 2022 Jun; 19(6):623-640. PubMed ID: 35611662
[TBL] [Abstract][Full Text] [Related]
13. Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.
Wu W; Luo L; Wang Y; Wu Q; Dai HB; Li JS; Durkan C; Wang N; Wang GX
Theranostics; 2018; 8(11):3038-3058. PubMed ID: 29896301
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
Majumder J; Minko T
Expert Opin Drug Deliv; 2021 Feb; 18(2):205-227. PubMed ID: 32969740
[TBL] [Abstract][Full Text] [Related]
15. Advances in intelligent-responsive nanocarriers for cancer therapy.
Tian M; Xin X; Wu R; Guan W; Zhou W
Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
[TBL] [Abstract][Full Text] [Related]
16. Endogenous and Exogenous Stimuli-Responsive Drug Delivery Systems for Programmed Site-Specific Release.
Raza A; Rasheed T; Nabeel F; Hayat U; Bilal M; Iqbal HMN
Molecules; 2019 Mar; 24(6):. PubMed ID: 30901827
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
18. Unveiling innovative therapeutic strategies and future trajectories on stimuli-responsive drug delivery systems for targeted treatment of breast carcinoma.
Naser IH; Zaid M; Ali E; Jabar HI; Mustafa AN; Alubiady MHS; Ramadan MF; Muzammil K; Khalaf RM; Jalal SS; Alawadi AH; Alsalamy A
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3747-3770. PubMed ID: 38095649
[TBL] [Abstract][Full Text] [Related]
19. Stimuli-responsive (nano)architectures for phytochemical delivery in cancer therapy.
Zandieh MA; Farahani MH; Daryab M; Motahari A; Gholami S; Salmani F; Karimi F; Samaei SS; Rezaee A; Rahmanian P; Khorrami R; Salimimoghadam S; Nabavi N; Zou R; Sethi G; Rashidi M; Hushmandi K
Biomed Pharmacother; 2023 Oct; 166():115283. PubMed ID: 37567073
[TBL] [Abstract][Full Text] [Related]
20. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
Tran VA; Vo VG; Shim K; Lee SW; An SSA
Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
